MAM
CME icon

Magellan Asset Management’s CME Group CME Stock Holding History

Magellan Asset Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.2M Sell
325,872
-326,288
-50% -$96.9M 1.25% 31
2025
Q4 		$178M Buy
652,160
+6,524
+1% +$1.77M 2.16% 17
2025
Q3 		$174M Buy
645,636
+159,569
+33% +$43.4M 2.07% 19
2025
Q2 		$134M Buy
486,067
+485,698
+131,625% +$132M 1.53% 27
2025
Q1 		$97.9K Sell
369
-53
-13% -$13.1K ﹤0.01% 85
2024
Q4 		$98K Sell
422
-1,572
-79% -$361K ﹤0.01% 83
2024
Q3 		$440K Sell
1,994
-5
-0.3% -$1.03K ﹤0.01% 90
2024
Q2 		$393K Buy
1,999
+293
+17% +$60.5K ﹤0.01% 92
2024
Q1 		$367K Sell
1,706
-132
-7% -$27.7K ﹤0.01% 93
2023
Q4 		$387K Sell
1,838
-17,682
-91% -$3.77M ﹤0.01% 91
2023
Q3 		$3.91M Sell
19,520
-2,321
-11% -$461K 0.04% 63
2023
Q2 		$4.05M Buy
21,841
+19,951
+1,056% +$3.69M 0.04% 64
2023
Q1 		$362K Buy
1,890
+63
+3% +$11.4K ﹤0.01% 89
2022
Q4 		$307K Sell
1,827
-124
-6% -$21.5K ﹤0.01% 91
2022
Q3 		$346K Sell
1,951
-142
-7% -$28.1K ﹤0.01% 87
2022
Q2 		$428K Sell
2,093
-13,891
-87% -$2.94M ﹤0.01% 82
2022
Q1 		$3.8M Sell
15,984
-2,262
-12% -$531K 0.01% 61
2021
Q4 		$4.17M Buy
18,246
+6,871
+60% +$1.51M 0.01% 52
2021
Q3 		$2.2M Buy
11,375
+4,664
+69% +$945K ﹤0.01% 60
2021
Q2 		$1.43M Buy
6,711
+863
+15% +$182K ﹤0.01% 63
2021
Q1 		$1.19M Buy
5,848
+1,750
+43% +$345K ﹤0.01% 61
2020
Q4 		$746K Buy
4,098
+858
+26% +$146K ﹤0.01% 62
2020
Q3 		$542K Sell
3,240
-130,820
-98% -$22M ﹤0.01% 60
2020
Q2 		$21.8M Buy
134,060
+1,097
+0.8% +$197K 0.07% 30
2020
Q1 		$23M Sell
132,963
-2,196,102
-94% -$437M 0.08% 24
2019
Q4 		$467M Buy
2,329,065
+9,375
+0.4% +$1.92M 1.23% 18
2019
Q3 		$490M Buy
2,319,690
+164,742
+8% +$34.4M 1.41% 18
2019
Q2 		$418M Buy
+2,154,948
New +$397M 1.2% 20

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Magellan Asset Management's CME Position: Q1 2026 in Review

Magellan Asset Management reduced its CME Group (CME) stake by 50% in Q1 2026, selling an estimated $96.9M and leaving 325,872 shares worth $96.2M. The position accounts for 1.25% of the portfolio, ranked #31.

Magellan Asset Management first reported a position in CME in Q2 2019 and has held it in 28 quarters since. The position peaked at $490M in Q3 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Magellan Asset Management held 325,872 shares of CME Group worth $96.2M as of Q1 2026.
  • Magellan Asset Management sold 326,288 CME Group shares in Q1 2026, an estimated $96.9M.
  • CME Group made up 1.25% of Magellan Asset Management's portfolio in Q1 2026, its #31 holding.
  • Magellan Asset Management first reported a position in CME Group in Q2 2019 and has held it in 28 quarters since.
  • Magellan Asset Management's CME Group position peaked at $490M in Q3 2019.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Magellan Asset Management's 13F filing for Q1 2026, filed 12 May 2026.